Opus Point Partners Management’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Opus Point Partners Management’s Portfolio OCRX Stock Details OCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-186,573	Closed	-$709K	–	65
2015 Q2	$709K	Buy	186,573 +3,900	+2%	+$15K	0.56%	43
2015 Q1	$860K	Buy	182,673 +60,000	+49%	+$346K	0.72%	37
2014 Q4	$781K	Buy	+122,673	New	+$718K	0.77%	38

Other funds holding OCRX

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Opus Point Partners Management's OCRX Position: Q3 2015 in Review

Opus Point Partners Management sold out of Ocera Therapeutics, Inc. (OCRX) in Q3 2015, closing a stake of 186,573 shares — an estimated $709K sold.

Opus Point Partners Management first reported a position in OCRX in Q4 2014 and held it in 3 quarters. The position peaked at $860K in Q1 2015. 27 funds tracked by Wall St. Rank hold OCRX as of Q3 2015.

Opus Point Partners Management reported no remaining Ocera Therapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
Opus Point Partners Management sold 186,573 Ocera Therapeutics, Inc. shares in Q3 2015, an estimated $709K.
Opus Point Partners Management first reported a position in Ocera Therapeutics, Inc. in Q4 2014 and held it in 3 quarters.
Opus Point Partners Management's Ocera Therapeutics, Inc. position peaked at $860K in Q1 2015.
27 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q3 2015.

Based on Opus Point Partners Management's 13F filing for Q3 2015, filed 16 Nov 2015.